PLS Group Ltd (ASX: PLS), Bendigo and Adelaide Bank Ltd (ASX: BEN), and Ampol Ltd (ASX: ALD) shares are creating a buzz today.

Two of the high-profile S&P/ASX 200 Index (ASX: XJO) are charging ahead of the 0.3% gains posted by the benchmark index in late morning trade on Monday, while one is in the red.

Here’s what’s grabbing investor interest.

Ampol shares jump on dividend boost

Ampol shares are up 2.5% at time of writing, changing hands for $40.85 apiece.

This follows the release of the Aussie fuel supplier’s half year results (H1 2026).

Highlights for the six months include a 152% year-on-year increase in Replacement Cost Operating Profit (RCOP) earnings before interest, taxes, depreciation and amortisation (EBITDA) to $1.64 billion (excluding significant items).

And on the bottom line, Ampol shares are getting a boost with the company reporting a statutory net profit after tax (NPAT) of $1.36 billion, up from a loss of $25 million in H1 2025.

And with profits surging, management declared a fully franked interim dividend of $1.85 per share, up a whopping 362.5% from last year’s interim payout.

Bendigo Bank shares slide on economic growth outlook

Unlike Ampol shares, Bendigo Bank shares are in the red today, down 1.1% at $10.38 each.

That comes as investors study the ASX 200 bank stock’s full year results release.

On the positive front, Bendigo Bank reported a 3.0% year-on-year increase in cash earnings to $530 million for the year. The bank also achieved a statutory net profit after tax of $375 million.

The fully franked final Bendigo Bank dividend of 33 cents per share was in line with last year’s final payout.

However, as with the other ASX 200 banks, investors may be favouring their sell buttons with an eye on a potentially slowing Aussie economy dragging on the Bendigo’s growth outlook.

The company noted:

Cost-of-living pressures due to higher inflation (especially since the Middle East conflict) have led to a sharp fall in consumer sentiment. Three RBA rate hikes, softening property prices and geopolitical events are expected to result in more modest economic growth this financial year.

Which bring us to…

PLS shares leap on return to profit

Joining Bendigo Bank and Ampol shares in the financial headlines on Monday, we find PLS, formerly known as Pilbara Minerals.

At the time of writing, shares in the ASX 200 lithium stock are up 7.3%, swapping hands for $5.44 apiece.

That strong performance follows the release of PLS own FY 2026 results.

Investors are responding positively, with PLS reporting a 152% year-on-year increase in revenue to $1.93 billion. PLS achieved a NPAT of $526 million, up from a net loss of $196 million last year.

And passive income investors will be celebrating the return of the PLS dividend. Management declared a final fully franked dividend of 5 cents per share.

PLS suspended its dividend payouts in 2024 amid cratering global lithium prices.

The post Why PLS, Bendigo Bank and Ampol shares are turning heads on Monday appeared first on The Motley Fool Australia.

More reading

• Everything you need to know about the PLS Group dividend
• Everything you need to know about the monster Ampol dividend
• These are the 10 most shorted ASX shares
• Ampol profit and dividend surge in first-half 2026 results
• Bendigo and Adelaide Bank FY26 earnings: profit lifts to $375.1 million, dividend steady

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Bendigo And Adelaide Bank. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are up 0.27% to 9,086.2 points as earnings season continues on Monday.

Among the 11 market sectors, materials and miners are in the lead today, up 1.7%.

The sector pushed higher amid BHP Group Ltd (ASX: BHP) shares reaching a new record of $67.72, up 3.9%, in early trading.

The financials sector is the laggard today, down 1%.

Let’s check out some new expert ratings on three ASX 200 sector heavyweights.

Pro Medicus Ltd (ASX: PME)

The Pro Medicus share price is $191.56, down 0.02% today and down 37% over 12 months. 

Pro Medicus shares jumped 7.1% last week after the company released its FY26 results.

The Pro Medicus share price is up 20% since the downtrodden healthcare sector pivoted on 3 June. 

Morgans maintained its accumulate rating on Pro Medicus shares after the report.

Analyst Iain Wilkie said: 

FY26 confirms PME is executing at an even higher level than the market gave it credit for. EBIT margin of 74.9% and constant currency EBIT growth of 30.6% both beat expectations comfortably, with the FX-driven softness in headline revenue a currency story, not a demand or execution one.

Momentum remains broad-based, implementations are ahead of schedule, renewals are a clean sweep, and the pipeline is opening up in new segments rather than just deepening in existing ones.

Looking ahead, FY27 is shaping as a genuine standout year. With four Trinity cohorts and 15 other implementations already banked rather than still ramping, the P&L gets the full run-rate benefit without needing fresh signings just to stand still.

Nothing in the result gives us any pause for change versus our positive view.

Fortescue Ltd (ASX: FMG)

The Fortescue share price is $18.08, up 1.8% today and down 10% over 12 months. 

Morgans has a hold rating on this ASX 200 mining share following the company’s FY26 report last week.

Analyst Adrian Prendergast said: 

A mixed FY26 result from FMG, with higher revenue helping to offset cost increases and elevated admin/R&D to help keep underlying earnings flat.

With the focus on FY27 guidance, Iron Bridge remained a key issue, with the magnetite operation struggling through ramp up and with elevated costs.

Plans for a green steel plant was big news, although difficult to quantify.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price is $155.24, down 1.7% today and down 9% over 12 months. 

CBA reported a 7% increase in its cash net profit after tax (NPAT) to $11 billion for FY26.

John Athanasiou from Red Leaf Securities has a sell rating on this ASX 200 bank share. 

He explained (courtesy The Bull):

CBA shares deserves to trade at a premium given its dominant retail franchise, strong technology platform, solid deposit base and consistent execution.

However, Australian banking remains a mature industry, with intense competition across mortgages and deposits limiting the potential for outsized earnings growth.

At a premium valuation, investors are paying a higher price for quality, leaving little room for disappointment.

After a substantial re-rating, investors may be better served taking some profits and reallocating capital towards businesses offering stronger growth at more reasonable valuations.

The post Buy, hold, sell: Pro Medicus, Fortescue, CBA shares appeared first on The Motley Fool Australia.

More reading

• Are Westpac shares a buy at their new 52-week low?
• Experts name CBA and these ASX shares as sells today
• How much do you need invested in ASX dividend shares to replace a $90,000 salary?
• ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus
• 5 things Warren Buffett looks for before buying ASX shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended BHP Group and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Westpac Banking Corp (ASX: WBC) shares have continued sliding since the bank’s latest quarterly update.

A new 52-week low naturally makes the shares look more tempting.

But has the investment case improved enough for me to buy?

The valuation has come down

Westpac shares touched a 52-week low of $33.46 on Monday, well below their 52-week high of $43.32.

That represents a decline of almost 23% from the peak and has taken some of the heat out of the valuation.

According to CommSec, analysts currently expect earnings per share of $2.08 in FY26 and $2.15 in FY27. At $33.46, Westpac is trading at around 16 times FY26 earnings and approximately 15.6 times FY27 earnings.

Those numbers look considerably more reasonable to me than they did when the shares were above $40.

Consensus forecasts also point to fully franked dividends of $1.54 per share in FY26 and $1.55 in FY27, so investors are still being offered a healthy stream of income while they wait.

But a cheaper share price alone is not enough to make me change my view.

My main concern hasn’t gone away

I wrote negatively about Westpac earlier this month after its third-quarter update, and the issue that bothered me then is still important today.

Mortgage applications have slowed.

Westpac reported average monthly mortgage applications of around 29,000 during the third quarter, while the run rate following the federal budget had fallen further to approximately 26,000.

That catches my attention because home lending remains a huge part of Westpac’s business. Its Australian mortgage portfolio stood at $529.1 billion at the end of June.

The bank also expects Australian housing credit growth to slow from 6.8% in FY26 to 4.7% in FY27.

Westpac is still profitable and its third-quarter update contained positives, including growth in business lending and deposits. But I would like to see clearer evidence that the bank can generate stronger growth outside its enormous mortgage business before becoming more positive.

The consensus numbers do not give me much reason to rush either. Earnings per share are currently expected to rise only modestly between FY26 and FY27, while the dividend forecast is almost unchanged.

I’d rather own CBA or NAB

If I wanted to buy an Australian bank today, I would still look elsewhere.

Commonwealth Bank of Australia (ASX: CBA) remains my preferred high-quality banking business.

I like its enormous customer franchise, strong digital capabilities, and ability to grow relationships across personal banking, home lending, business banking, and other financial services.

National Australia Bank Ltd (ASX: NAB) also interests me more than Westpac.

NAB’s strong position in business banking gives it exposure to an area I find attractive, particularly when competition and slower growth can make Australian home lending more challenging.

Westpac is working to strengthen its own business banking operations, including adding more regional bankers. That could help over time.

For now, though, I think CBA and NAB give me stronger reasons to invest.

Foolish takeaway

The new 52-week low has made Westpac shares more reasonably priced, but I am still not a buyer.

I would want more than a falling share price to change my mind. The slowdown in mortgage applications remains a concern, while current forecasts suggest earnings growth could be fairly subdued in the near term.

Westpac could certainly recover from here, and its dividend may attract income investors.

For my own money, though, I would rather put it behind CBA or NAB and wait for stronger evidence before reconsidering Westpac.

The post Are Westpac shares a buy at their new 52-week low? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: CSL, BHP, Westpac shares
• Experts name CBA and these ASX shares as sells today
• How much do you need invested in ASX dividend shares to replace a $90,000 salary?
• 5 things Warren Buffett looks for before buying ASX shares
• 3 reasons to buy CBA shares following its results

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.